The Effect of Weight Loss and Dietary Protein Intake on Bone

Sponsor
Rutgers University (Other)
Overall Status
Completed
CT.gov ID
NCT00473031
Collaborator
National Institute on Aging (NIA) (NIH)
48
1
2
39
1.2

Study Details

Study Description

Brief Summary

The purpose of this study is to learn how the amount of protein during moderate weight loss influences bone health. We will also examine how two levels of protein intake affects diet quality.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Caloric restriction, high protein
  • Behavioral: Caloric restriction; normal protein
  • Behavioral: Counseling
N/A

Detailed Description

It is unclear whether protein intake during dieting influences bone density. This information is important for determining optimal nutrient requirements during weight loss. This study will compare the effects of weight loss with a lower-carbohydrate, high-protein (HP) diet to a high-carbohydrate, moderate protein (HC) diet on bone mass and quality in postmenopausal women (ages 50-70 years) with the hypothesis that bone turnover and loss of bone will be reduced on the HP compared to the HC weight loss diet. In a secondary aim, we will examine bone markers, hormones and the impact of protein intake on diet quality.

Participants will be randomly assigned to one of 2 groups: A) weight loss with recommended level of protein intake, and B) weight loss with higher protein intake. All participants will attend regular counseling sessions (about 50 minutes per session) with a dietitian for approximately 1 year, and will be asked to take a daily vitamin/mineral supplement. Also, depending on their usual food intake, they may be asked to take a calcium tablet to meet the recommended intake throughout the study period. Bone, mineral, protein and lipid markers, and hormones that influence bones will be measured. These measurements will provide information about body composition (fat, muscle mass, and bone mineral density). Participants will be asked to attend 8 diet counseling sessions, with the opportunity to attend a total of approximately 28 diet counseling sessions during the year.

Study Design

Study Type:
Interventional
Actual Enrollment :
48 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Nutritional Regulation of Bone - Aim 1
Study Start Date :
Mar 1, 2007
Actual Primary Completion Date :
Jun 1, 2010
Actual Study Completion Date :
Jun 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

High Protein

Behavioral: Caloric restriction, high protein
Weight loss with higher protein (35%) intake

Behavioral: Counseling
Participants will be asked to attend eight 50-minute diet counseling sessions, with the opportunity to attend a total of approximately 28 diet counseling sessions, during the year.

Active Comparator: 2

Normal Protein

Behavioral: Caloric restriction; normal protein
Weight loss with recommended level of protein (18%)intake

Behavioral: Counseling
Participants will be asked to attend eight 50-minute diet counseling sessions, with the opportunity to attend a total of approximately 28 diet counseling sessions, during the year.

Outcome Measures

Primary Outcome Measures

  1. Changes in Bone density and quality [one year]

Secondary Outcome Measures

  1. Changes in serum and urine bone markers, hormones, and proteins [one year]

  2. Nutrient Adequacy & Diet Quality with normal & higher protein intake [one year]

    healthy eating index score

Other Outcome Measures

  1. Glomerular Filtration Rate with two levels of protein intake [one year]

    GFR

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 70 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Postmenopausal women who are more than 2 years since last menses

  • Obese or overweight

  • Must live in the geographic vicinity of Rutgers University

Exclusion Criteria:
  • Currently on any medication known to influence calcium or bone metabolism, including HRT, or with evidence of diseases known to influence calcium metabolism (i.e. metabolic bone disease, hyperparathyroidism, untreated thyroid disease, significant immune, hepatic, or renal disease, significant cardiac disease [i.e., heart attack or stroke in the past 6 months., abnormal EKG], active malignancy or cancer therapy within the past year)

  • History of kidney stones

  • Weight gain or weight loss (5% of body wt) within 3 months prior to recruitment

  • Participation in other investigational studies during the 12-month study period

  • Usually have a very high or low intake of calcium (more than 1500 or less than 500 mg per day)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rutgers University New Brunswick New Jersey United States 08901

Sponsors and Collaborators

  • Rutgers University
  • National Institute on Aging (NIA)

Investigators

  • Principal Investigator: Sue A. Shapses, PhD, Rutgers University, Nutritional Sciences

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Sue A. Shapses, Ph.D., RD, Professor, Rutgers University
ClinicalTrials.gov Identifier:
NCT00473031
Other Study ID Numbers:
  • AG0079
  • R01AG012161
  • FP00011588
First Posted:
May 14, 2007
Last Update Posted:
Feb 1, 2022
Last Verified:
Jan 1, 2022
Keywords provided by Sue A. Shapses, Ph.D., RD, Professor, Rutgers University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 1, 2022